Liqing Wang

机构：Hebei Medical University, Texas A&M Health Science Center, Children's Hospital of Philadelphia, North University of China, Sun Yat-sen University, Laboratoire de Chémo-biologie synthétique et thérapeutique, Second Hospital of Hebei Medical University, Third Affiliated Hospital of Sun Yat-sen University, Texas A&M University, KU Leuven · ORCID：0009-0000-9896-3793

发表论文 60 篇 · 总被引 685 次 · h-index 15

代表论文

• Insights Into the Pathologic Roles and Regulation of Eukaryotic Elongation Factor-2 Kinase (2021 · Frontiers in Molecular Biosciences · 被引 32)
• Tumorous expression of NAC1 restrains antitumor immunity through the LDHA-mediated immune evasion (2022 · Journal for ImmunoTherapy of Cancer · 被引 27)
• Control of CD4+ T cells to restrain inflammatory diseases via eukaryotic elongation factor 2 kinase (2023 · Signal Transduction and Targeted Therapy · 被引 25)
• NAC1 modulates autoimmunity by suppressing regulatory T cell–mediated tolerance (2022 · Science Advances · 被引 23)
• Guanidinium-rich lipopeptide functionalized bacteria-absorbing sponge as an effective trap-and-kill system for the elimination of focal bacterial infection (2022 · Acta Biomaterialia · 被引 19)
• Elongation factor-2 kinase is a critical determinant of the fate and antitumor immunity of CD8 + T cells (2022 · Science Advances · 被引 14)